These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25329636)

  • 1. Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes.
    Quinteros D; Vicario-de-la-Torre M; Andrés-Guerrero V; Palma S; Allemandi D; Herrero-Vanrell R; Molina-Martínez IT
    PLoS One; 2014; 9(10):e110344. PubMed ID: 25329636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes.
    Andrés-Guerrero V; Molina-Martínez IT; Peral A; de las Heras B; Pintor J; Herrero-Vanrell R
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1507-15. PubMed ID: 21087964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
    Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
    Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers.
    Andrés-Guerrero V; Vicario-de-la-Torre M; Molina-Martínez IT; Benítez-del-Castillo JM; García-Feijoo J; Herrero-Vanrell R
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3548-56. PubMed ID: 21296826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.
    Pintor J; Peláez T; Hoyle CH; Peral A
    Br J Pharmacol; 2003 Mar; 138(5):831-6. PubMed ID: 12642384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes.
    Serle JB; Wang RF; Peterson WM; Plourde R; Yerxa BR
    J Glaucoma; 2004 Oct; 13(5):385-8. PubMed ID: 15354076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice.
    Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Pintor J
    J Pharmacol Exp Ther; 2016 May; 357(2):293-9. PubMed ID: 26941171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pineal Res; 2012 Apr; 52(3):265-70. PubMed ID: 22107075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment.
    Crooke A; Huete-Toral F; Martínez-Águila A; Alarma-Estrany P; Pintor J
    Pharmacogenet Genomics; 2011 Sep; 21(9):587-9. PubMed ID: 21705965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Melatonin and Its Analogs on Tear Secretion.
    Navarro Gil FJ; Huete-Toral F; Crooke A; Dominguez Godinez CO; Carracedo G; Pintor J
    J Pharmacol Exp Ther; 2019 Oct; 371(1):186-190. PubMed ID: 31371479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
    Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde R; Pelaez T; Yerxa B; Pintor J
    J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit.
    Alarma-Estrany P; Crooke A; Pintor J
    J Pineal Res; 2009 Sep; 47(2):201-209. PubMed ID: 19627460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.
    Alarma-Estrany P; Crooke A; Peral A; Pintor J
    Auton Neurosci; 2007 Dec; 137(1-2):63-6. PubMed ID: 17804303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit.
    Leonardi A; Bucolo C; Drago F; Salomone S; Pignatello R
    Int J Pharm; 2015 Jan; 478(1):180-186. PubMed ID: 25448580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites.
    Molinari EJ; North PC; Dubocovich ML
    Eur J Pharmacol; 1996 Apr; 301(1-3):159-68. PubMed ID: 8773460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.
    Natarajan JV; Ang M; Darwitan A; Chattopadhyay S; Wong TT; Venkatraman SS
    Int J Nanomedicine; 2012; 7():123-31. PubMed ID: 22275828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension.
    Abd-Elsalam WH; ElKasabgy NA
    Int J Pharm; 2019 Apr; 560():235-245. PubMed ID: 30763680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits.
    Pintor J; Martin L; Pelaez T; Hoyle CH; Peral A
    Eur J Pharmacol; 2001 Mar; 416(3):251-4. PubMed ID: 11290376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand.
    Vincent L; Cohen W; Delagrange P; Boutin JA; Nosjean O
    J Pineal Res; 2010 Apr; 48(3):222-229. PubMed ID: 20210850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.